Condensed Consolidated Statements of Convertible Preferred Stock and Stockholder's Deficit - USD ($) $ in Thousands	Total	Series A Convertible Preferred Stock	Series B Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		0	0
Beginning balance at Dec. 31, 2022		$ 0	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of preferred stock (in shares)		30,000
Issuance of preferred stock		$ 3,867
Preferred stock issuance costs		(253)
Accretion on convertible preferred stock		$ 653
Ending balance (in shares) at Mar. 31, 2023		30,000	0
Ending balance at Mar. 31, 2023		$ 4,267	$ 0
Beginning balance (in shares) at Dec. 31, 2022				8,242,009
Beginning balance at Dec. 31, 2022	$ (10,635)			$ 1	$ 212,122	$ (222,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on Series A convertible preferred stock	(653)				(653)
Issuance of SVB Warrants (Note 4)	43				43
Issuance of common stock upon exercise of stock options (in Shares)				18,054
Issuance of common stock upon exercise of stock options	55				55
Issuance of common stock for restricted stock units vesting (in shares)				115,257
Issuance of common stock for employee stock purchase plans (in shares)				15,104
Issuance of common stock for employee stock purchase plan	101				101
Stock-based compensation	2,789				2,789
Net income (loss)	(11,867)					(11,867)
Ending balance (in shares) at Mar. 31, 2023				8,390,424
Ending balance at Mar. 31, 2023	(20,167)			$ 1	214,457	(234,625)
Beginning balance (in shares) at Dec. 31, 2022		0	0
Beginning balance at Dec. 31, 2022		$ 0	$ 0
Ending balance (in shares) at Jun. 30, 2023		30,000	0
Ending balance at Jun. 30, 2023		$ 5,593	$ 0
Beginning balance (in shares) at Dec. 31, 2022				8,242,009
Beginning balance at Dec. 31, 2022	(10,635)			$ 1	212,122	(222,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(20,334)
Ending balance (in shares) at Jun. 30, 2023				8,441,683
Ending balance at Jun. 30, 2023	(27,316)			$ 1	215,775	(243,092)
Beginning balance (in shares) at Mar. 31, 2023		30,000	0
Beginning balance at Mar. 31, 2023		$ 4,267	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion on convertible preferred stock	(1,326)	$ 1,326			(1,326)
Ending balance (in shares) at Jun. 30, 2023		30,000	0
Ending balance at Jun. 30, 2023		$ 5,593	$ 0
Beginning balance (in shares) at Mar. 31, 2023				8,390,424
Beginning balance at Mar. 31, 2023	(20,167)			$ 1	214,457	(234,625)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for restricted stock units vesting (in shares)				51,259
Stock-based compensation	2,644				2,644
Net income (loss)	(8,467)					(8,467)
Ending balance (in shares) at Jun. 30, 2023				8,441,683
Ending balance at Jun. 30, 2023	(27,316)			$ 1	215,775	(243,092)
Beginning balance (in shares) at Dec. 31, 2023		28,628	0
Beginning balance at Dec. 31, 2023		$ 7,855	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of preferred stock (in shares)		0	9,250
Issuance of preferred stock		$ 0	$ 2,394
Preferred stock issuance costs		0	(102)
Accretion on convertible preferred stock		$ 1,212	$ 116
Conversion of preferred stock (in shares)		(1,178)
Conversion of preferred stock		$ (332)
Ending balance (in shares) at Mar. 31, 2024		27,450	9,250
Ending balance at Mar. 31, 2024		$ 8,735	$ 2,408
Beginning balance (in shares) at Dec. 31, 2023				8,797,456
Beginning balance at Dec. 31, 2023	(37,531)			$ 1	218,127	(255,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stock issuance costs	0				0
Accretion on Series A convertible preferred stock	$ (1,328)				$ (1,328)
Conversion of preferred stock	332,000			171,719	332,000
Issuance of common stock for restricted stock units vesting (in shares)				22,437
Issuance of common stock for employee stock purchase plans (in shares)				22,791
Issuance of common stock for employee stock purchase plan	$ 92				$ 92
Stock-based compensation	2,227				2,227
Net income (loss)	3,274					3,274
Ending balance (in shares) at Mar. 31, 2024				9,014,403
Ending balance at Mar. 31, 2024	(32,934)			$ 1	219,450	(252,385)
Beginning balance (in shares) at Dec. 31, 2023		28,628	0
Beginning balance at Dec. 31, 2023		$ 7,855	$ 0
Ending balance (in shares) at Jun. 30, 2024		27,200	9,250
Ending balance at Jun. 30, 2024		$ 9,839	$ 2,756
Beginning balance (in shares) at Dec. 31, 2023				8,797,456
Beginning balance at Dec. 31, 2023	(37,531)			$ 1	218,127	(255,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	2,127
Ending balance (in shares) at Jun. 30, 2024				9,099,539
Ending balance at Jun. 30, 2024	(33,429)			$ 1	220,102	(253,532)
Beginning balance (in shares) at Mar. 31, 2024		27,450	9,250
Beginning balance at Mar. 31, 2024		$ 8,735	$ 2,408
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion on convertible preferred stock		$ 1,187	$ 348
Conversion of preferred stock (in shares)		(250)
Conversion of preferred stock		$ (83)
Ending balance (in shares) at Jun. 30, 2024		27,200	9,250
Ending balance at Jun. 30, 2024		$ 9,839	$ 2,756
Beginning balance (in shares) at Mar. 31, 2024				9,014,403
Beginning balance at Mar. 31, 2024	(32,934)			$ 1	219,450	(252,385)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion on Series A convertible preferred stock	$ (1,535)				$ (1,535)
Conversion of preferred stock	83,000			36,443	83,000
Issuance of common stock for restricted stock units vesting (in shares)				48,693
Stock-based compensation	$ 2,104				$ 2,104
Net income (loss)	(1,147)					(1,147)
Ending balance (in shares) at Jun. 30, 2024				9,099,539
Ending balance at Jun. 30, 2024	$ (33,429)			$ 1	$ 220,102	$ (253,532)